Company Monitoring Page for Alexion

latest headlines for company on cafepharma

Are Biotech M&A Premiums Already Built In? Valuations Do Matter
Seeking Alpha
Tue, 09/3/13 - 04:19 pm
Tags:
biotech, M&A, ONYX Pharmaceuticals, Alexion, Biomarin, Incyte, Medivation, Pharmacyclics, Regeneron, Seattle Genetics
What Does The FDA's Breakthrough Designation Mean For Investors?
Seeking Alpha
Mon, 08/26/13 - 01:28 pm
Tags:
FDA, breakthrough therapies, AbbVie, Alexion, Ariad Pharmaceuticals, Biomarin, Bristol-Myers Squibb, SynaGeva BioPharma, GSK, JNJ, Merck, Novartis, Pharmacyclics, Pfizer, Vertex Pharmaceuticals, daratumumab, ibrutinib, Kalydeco, lambrolizumab, palbociclib, LDK378, SD-101, obinutuzumab, serelaxin, asfotase alfa, bimagrumab, drisapersen, sebelipase alfa
Alexion: Is There Any Remaining Value in This Industry Leader?
Motley Fool
Thu, 08/22/13 - 10:36 am
Tags:
Alexion, Soliris
Which Of These Smaller Companies Could Roche Buy?
Motley Fool
Sat, 08/17/13 - 10:50 am
Tags:
Roche, M&A, Celldex, ImmunoCellular Therapeutics, Immunomedics, Alexion
Between RX and A Hard Place: Biotechs Flash Warnings
Investors.com
Tue, 08/13/13 - 11:00 am
Tags:
Alexion, BiogenIdec, Santarus, Regeneron
3 Biotech Favorites With Noteworthy Drug Data
Motley Fool
Mon, 07/29/13 - 03:05 pm
Tags:
Alexion, Biogen Idec, Soliris, Celgene, Revlimid, Tecfidera
Alexion's 2Q profit soars as Soliris sales jump
Yahoo/AP
Thu, 07/25/13 - 11:22 am
Tags:
Alexion, earnings
5 Drugmakers With a Lot on the Line Next Week
Motley Fool
Sun, 07/21/13 - 11:37 am
Tags:
Eli Lilly, InterMune, Gilead Sciences, Alexion, Biomarin
Alexion, Ensemble Therapeutics collaborate to find macrocycle drug candidate
Yahoo/Fly on the Wall
Thu, 07/18/13 - 09:52 am
Tags:
Alexion, Ensemble Therapeutics, macrocycle drugs
4 Reasons This Biotech Went up by 400 Percent
Motley Fool
Wed, 07/17/13 - 12:36 pm
Tags:
Celldex, Alexion, Roche
Alexion Takeover Would Be Priciest Since 2008: Real M&A
Bloomberg
Tue, 07/16/13 - 11:21 am
Tags:
Alexion, Roche, M&A
Is Big Pharma Crazy for Chasing This Deal?
Motley Fool
Tue, 07/16/13 - 10:27 am
Tags:
Alexion, Roche, M&A
The Best- And Worst-Performing Biotech Stocks July 5 To July 12
Forbes
Mon, 07/15/13 - 11:21 am
Tags:
Vivus, Trius Therapeutics, Prosensa, Pharmacyclics, NxStage Medical, Natus Medical, MiMedx, Merrimack Pharmaceuticals, Intuitive Surgical, InterMune, GTx, Fluidigm, Epizyme, Celldex, Astex, Analogic, Amarin, Alnylam, Alexion, AcelRx
[video] Why Roche May Want to Acquire Alexion
Bloomberg
Mon, 07/15/13 - 11:16 am
Tags:
Roche, Alexion, M&A, Soliris
Alexion valuation could choke any Roche bid
Yahoo/Reuters
Sun, 07/14/13 - 11:22 am
Tags:
Alexion, Roche, M&A
This Week in Biotech
Motley Fool
Sun, 07/14/13 - 11:19 am
Tags:
Pharmacyclics, JNJ, Alnylam, Inovio, Alexion, Roche
Alexion rockets on Roche buyout speculation
Yahoo/AP
Sat, 07/13/13 - 11:39 am
Tags:
Alexion, Roche, M&A
Roche seeks financing for potential Alexion takeover: sources
Reuters
Fri, 07/12/13 - 03:50 pm
Tags:
Roche, Alexion, M&A
3 Best-Run Biotech Companies
Motley Fool
Sun, 06/23/13 - 11:12 am
Tags:
Biogen Idec, Alexion, Questcor Pharmaceuticals
The Profitable Business of Developing Orphan Drugs
Motley Fool
Tue, 06/4/13 - 12:44 pm
Tags:
orphan drugs, NPS Pharmaceuticals, Gattex, Soliris, Alexion, Genzyme, Renagel, Cerezyme, Fabrazyme, Sanofi

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.